Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David J. Weissberg, MD, FAAOS, PC
September 20 2018 - 10:41AM
InvestorsHub NewsWire
Canbiola, Inc. (OTC PINK: CANB) Announces the Addition of Dr. David
J. Weissberg, MD, FAAOS, PC
HICKSVILLE, NY -- September 20, 2018 -- InvestorsHub
NewsWire -- Canbiola, Inc. (OTC PINK: CANB) in its
continuing effort to attract and partner with industry experts in
the Global Health and Wellness field is proud to announced today
that Dr. David J. Weissberg is joining the Medical Advisory Board
and has also signed on as a Private Label customer.
Dr. Weissberg stated, “I’m very pleased to join the Medical
Advisory team, to both collaborate on new products and explore the
benefits of CBD for patients. To date, I have used this product on
both myself and dozens of my patients and have been very satisfied
with both the potent non-narcotic pain relief it affords my
patients as well as the low risk of adverse side effects commonly
seen in both traditional non-steroidal anti-inflammatory drugs and
narcotic medications. CBD has very potent anti-inflammatory
properties bringing down the swelling, stiffness, and warmth seen
in arthritic joints and post-traumatic injuries. I believe that
many physician specialties will find good indications for its use
making it a very affordable and safe medication without the high
risks associated with traditional prescription drugs. Additionally,
Chiropractors who are unable to prescribe medications will be able
to offer this over the counter medication for their patients who
frequently suffer from both post-traumatic and neurologic injuries.
The research and results thus far are very compelling and I’m
excited for the prospects these products will offer for a variety
of ailments. I will strive to help the Canbiola team put the best
products possible on the market for both consumers and
patients”.
Marco Alfonsi, Canbiola CEO, stated, “We are continuing to
execute our plan to strengthen not only our Medical Advisory Board
but also our distribution network. With the addition of Dr.
Weissberg, we have added the 8th doctor to our Medical Advisory
Board. I believe this addition will benefit our product
development, to have true medical experts advise and offer input as
we develop new products is an invaluable resource. Coupling the
continued and increased acceptance of CBD with our development of
new products for different uses will continue our growth and sales
while expanding our client base. At Canbiola we are building an
extraordinary team, and look to be an industry leader going
forward. My enthusiasm for our future and the direction of the
industry as a whole is very strong, I want to thank our team and
shareholders for their support.”
Dr. Weissberg joins a growing all-star medical advisory team
that already has the following members:
Dr. Maciej Matt Ferenc joins Canbiola as Medical Advisor and
Distributor
Dr. Channing Coe joins Canbiola as Medical Advisor and
Distributor
Dr. Robert A. Kornfeld Joins Canbiola, Inc. (CANB) as Medical
Advisor and Distributor
Dr. John P. Salerno Joins Canbiola, Inc. (CANB) as Medical
Advisor and Distributor
Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical
Advisor and Distributor
Dr. Harry Benisatto joins Canbiola, Inc. (CANB) as Medical
Advisor and Distributor
Dr. Smita Ohri joins Canbiola as Medical Advisor and
Distributor
About Dr. Weissberg:
Over 25 years in private practice, Dr. Weissberg has honed a
meticulous and moderate approach to orthopedic care. A co-owner of
the Melville Surgery Center and certified in the ImPACT™ Protocol –
served as team physician for the Huntington, Walt Whitman, and
Northport high school football teams, he is expert in the diagnosis
and treatment of musculoskeletal injuries and conditions. He
specializes in the arthroscopic treatment of shoulder, knee and
ankle problems, including meniscal injuries, anterior cruciate
ligament tears, labral and rotator tears, impingement syndromes,
and instability issues.
Long Island Orthopedic Solutions (6 locations and
30,000+ patients)
Comprehensive, Conservative Treatment and Rehabilitation
Options
That’s Long Island Orthopedic Solutions: minimal invasion with
maximum results. The most advanced technological treatments and
physical therapy combine to encourage the body’s natural healing
abilities, providing quicker results while often avoiding
traditional surgical options.
With over five decades of combined experience, our clinical
staff is expert in time-tested medicines and therapies and the
latest diagnosis and treatment protocols, including surgical and
nonsurgical orthopedic solutions and ImPACT™ (Immediate
Post-Concussion Assessment and Cognitive Testing) computerized
evaluation tools and services.
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a
variety of Cannabidiol (CBD) based products. Canbiola is in the
process of developing its own line of proprietary products as well
as seeking synergistic value through acquisitions in the CBD and
the medical cannabis industry. Cannabis is currently federally
illegal and has legalized for medical purposes in some form in a
limited number of states. The company has already launched several
products found at www.canbiola.com.
The company also owns two technological solutions, WRAPmail (US
Patent 8,572,275), which turns traditional email into a powerful
marketing and branding tool, as well Prosperity Systems and the
Bullseye platform of document management and compliance targeted at
broker-dealers, public companies, and governmental agencies
providing a flawless all-in-one solution for document management,
retention and compliance.
Forward-looking statements and risks and uncertainties Matters
discussed in this press release contain forward-looking statements.
The words "anticipate," "believe," "estimate," "may," "intend,"
"expect," and similar expressions identify such forward-looking
statements. Expected, actual results, performance, or achievements
could differ materially from those contemplated, expressed, or
implied by the forward-looking statements contained herein.
Forward-looking statements are subject to a number of risks and
uncertainties, including but not limited to, risks and
uncertainties associated with, among other things, the impact of
economic, competitive, and other factors affecting our operations,
markets, products, and performance. The matters discussed herein
should not be construed in any way, shape or manner of our future
financial condition or stock price.
Follow us on Twitter and Facebook
CONTACT INFORMATION
Canbiola Investor Relations
Email: IR@canbiola.com
Phone: (516) 595-9544
Website: http://www.canbiola.com
Follow us on Twitter and Facebook
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024